Levamisol Production Cost Reports

The report provides a detailed analysis essential for establishing a Levamisole production plant. It encompasses all critical aspects necessary for Levamisole production, including the cost of Levamisole production, Levamisole plant cost, Levamisole production costs, and the overall Levamisole production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Levamisole production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Levamisole is an anthelmintic and immunomodulatory compound that finds wide applications in the pharmaceutical and veterinary industries. It is primarily used as an anthelmintic agent for the treatment and control of parasitic worm infections in humans and animals, such as cattle, sheep, and pigs. It finds its main application in veterinary medicine, particularly in livestock such as cattle, sheep, and pigs, for controlling gastrointestinal parasites. It helps in improving animal health and productivity by effectively eliminating gastrointestinal and lung worms. It is also used as an immunomodulatory agent in human medicine to enhance the body’s immune response in certain medical treatments, including autoimmune diseases and cancers. It is often used as an additive in some pharmaceutical formulations to enhance the effectiveness of other drugs. Additionally, it is also used in research laboratories for studying immune responses and enzyme activity due to its stimulating effects on the immune system.

The demand for Levamisole is driven by its application as an anthelmintic agent for treating and controlling parasitic worm infections in livestock, which significantly contributes to its market growth. Its usage as a drug in improving animal health and productivity further enhances its demand in the veterinary and animal healthcare industries. Moreover, its application as an immunomodulatory agent in human medicine and its use in research to study immune responses also promote its demand in the medical and healthcare industries. Various important factors, including the availability and cost of raw materials, compliance with pharmaceutical and veterinary regulations, and adherence to quality standards, affect the global Industrial Levamisole procurement. Other major factors, such as supplier networks and advancements in drug formulation and production technology, also significantly influence its overall market and procurement processes.

Raw Material for Levamisole Production

According to the Levamisole production plant project report, the major raw materials for Levamisole production include Styrene Oxide - 2-imino-1,3-thiazolidine - Thionyl chloride- Acetic anhydride; Styrene Oxide- Aziridine- Potassium isothiocyanate (KSCN) or Thiourea- Thionyl chloride- Acetic anhydride.

Production Processes of Levamisole

The extensive Levamisole production cost report consists of the following industrial production process:

1. Production from Styrene Oxide: In the styrene oxide-based synthesis of Levamisole, styrene oxide serves as the primary starting material, reacting directly with 2-imino-1,3-thiazolidine. The reaction forms 3-(2-phenyl-2-hydroxyethyl)-2-imino-1,3-thiazolidine as an intermediate. Then, the hydroxyl group in this compound is replaced with chlorine by treating it with thionyl chloride, which produces the corresponding chloro derivative. Finally, heating the obtained intermediate with acetic anhydride promotes cyclisation and acetylation, which results in the formation of 2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]thiazole or Levamisole as the final product.
    
2. Production via Aziridine–Thiourea Route- In this method, styrene oxide is first reacted with aziridine to form 2-aziridion-1-phenylethanol-1. Then, this intermediate is treated with potassium isothiocyanate or thiourea, which converts it into 3-(2-phenyl-2-hydroxyethyl)-2-amino-1,3-thiazolidine. The hydroxyl group of this compound is replaced with chlorine by treatment with thionyl chloride. Further, the compound is subjected to heating with acetic anhydride, which induces ring closure, leading to the formation of Levamisole as the desired product. This method provides an efficient pathway, as it uses inexpensive and readily available reagents.

Levamisole is a synthetic imidazothiazole compound used to treat parasitic worm infections and certain autoimmune conditions. It exists in the form of a white to off-white crystalline powder with no characteristic odour. The compound is slightly soluble in water, freely soluble in chloroform, and sparingly soluble in ethanol. The molecular formula of the compound is C11H12N2S, and its molecular weight is 204.29 g/mol. The density of the compound is approximately 1.3 g/cm³. Levamisole has a melting point of about 59–61 degree Celsius, and it undergoes thermal decomposition upon further heating. It remains stable under normal conditions but may degrade when exposed to light or moisture. The compound is toxic if ingested in large quantities and may cause adverse effects such as nausea, skin reactions, and agranulocytosis upon prolonged exposure. It is recommended to take proper protective measures while handling this substance.